| Authors: |
Le H; Pfizer, 66 Hudson Blvd E, New York, NY 10001, USA. Electronic address: hannahlepharmd@gmail.com., Coulter J; Pfizer, 66 Hudson Blvd E, New York, NY 10001, USA. Electronic address: joshua.coulter@pfizer.com., Culver K; ALK Positive Inc, 6595 Roswell Road, Suite G2310, Atlanta, GA 30328, USA. Electronic address: ken.culver@alkpositive.org., Cappelleri JC; Pfizer, 66 Hudson Blvd E, New York, NY 10001, USA. Electronic address: joseph.c.cappelleri@pfizer.com., Rifi N; Pfizer, 66 Hudson Blvd E, New York, NY 10001, USA. Electronic address: nada.rifi@pfizer.com., Lu H; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK. Electronic address: hui.lu@thermofisher.com., Quaife M; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK. Electronic address: matt.quaife@thermofisher.com., Meginnis K; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK. Electronic address: keila.meginnis@thermofisher.com., Fernandez GS; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK. Electronic address: gabriela.fernandez@thermofisher.com., Vaghela S; HealthEcon Consulting, Inc, Ancaster, ON L9G 4L2, Canada. Electronic address: shailja@healthecons.com., Hauber B; Pfizer, 66 Hudson Blvd E, New York, NY 10001, USA. Electronic address: albert.hauber@pfizer.com., Stinchcombe TE; Duke Cancer Institute, DUMC 3198, 25178 Morris Building, Durham, NC 27710, USA. Electronic address: thomas.stinchcombe@duke.edu. |
